(Q33415447)

26 July 2017

1 reference

title

High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses (English)

1 reference

26 July 2017

Etzioni A

1

1 reference

26 July 2017

Pollack S

series ordinal

2

1 reference

26 July 2017

publication date

1 January 1989

1 reference

26 July 2017

1 reference

26 July 2017

volume

3

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

307-315

1 reference

Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Non-A, non-B hepatitis from intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

High-dose intravenous IgG in adults with autoimmune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Kawasaki disease: review of risk factors for coronary aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

High-dose gammaglobulin therapy for Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Kawasaki disease: clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Gamma-globulin therapy in 6 newly diagnosed diabetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Effect of intravenous immunoglobulin in immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Correlation of in vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916938908997101

10.3109/08916938908997101

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference